Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
Bowen Liu(University of Science and Technology Beijing), Lihong Ye(Nankai University), Lu Zhang(China Pharmaceutical University), Tianjiao Wang(China University of Petroleum, Beijing), Leilei Li(Hainan Medical University), Weiying Zhang(Shanghai University of Traditional Chinese Medicine), Yue Wu(Chongqing University), Xiaoli Cai(Wuhan University of Science and Technology), Runping Fang(Virginia Commonwealth University), Huawei Wang(Chinese PLA General Hospital), Feifei Xu(Tongji University)
Cited by 73
Related Papers
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
|Nature Communications|2021|325
Mitochondrial genome evidence reveals successful Late Paleolithic settlement on the Tibetan Plateau
|Proceedings of the National Academy of Sciences|2009|272
Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol
|Science|2020|178